Fulgent Genetics (FLGT) Total Current Liabilities (2015 - 2026)

Fulgent Genetics (FLGT) has 12 years of Total Current Liabilities data on file, last reported at $90.1 million in Q1 2026.

• Quarterly Total Current Liabilities rose 36.74% year-over-year to $90.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $90.1 million (up 36.74% YoY) and the FY2025 annual result came in at $85.0 million, up 16.55% from the prior year.
• Total Current Liabilities improved to $90.1 million in Q1 2026 per FLGT's latest filing, from $85.0 million in the prior quarter.
• The five-year high for Total Current Liabilities was $141.7 million in Q1 2022, with the low at $61.4 million in Q3 2023.
• Average Total Current Liabilities over 5 years is $83.8 million, with a median of $75.8 million recorded in 2024.
• Year-over-year, Total Current Liabilities slumped 49.17% in 2023 and surged 36.74% in 2026.
• Fulgent Genetics' Total Current Liabilities stood at $88.1 million in 2022, then fell by 17.13% to $73.0 million in 2023, then retreated by 0.16% to $72.9 million in 2024, then rose by 16.55% to $85.0 million in 2025, then climbed by 6.08% to $90.1 million in 2026.
• Business Quant data shows FLGT's Total Current Liabilities at $90.1 million in Q1 2026, $85.0 million in Q4 2025, and $72.4 million in Q3 2025.